561. Safety of Remdesivir vs Standard Care in Patients with Moderate Covid-19

BACKGROUND: Remdesivir (RDV) has been shown to shorten recovery time and was well tolerated in patients with severe COVID-19. Here we report safety of RDV in patients with moderate COVID-19. METHODS: We conducted an open-label, phase 3 trial (NCT04252664) in hospitalized patients with confirmed SARS...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Open Forum Infect Dis
Main Authors: Criner, Gerard J, Ahn, Mi Young, Huhn, Gregory, Subramanian, Aruna, Lumbreras, Carlos, Schmiedel, Stefan, Hyland, Robert H, Suri, Vithika, Cao, Huyen, Wang, Hongyuan, SenGupta, Devi, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Chen, Yao-Shen, Günthard, Huldrych, Sanz-Moreno, D Jose, Aberg, Judith A, Nicastri, Emanuele, Tsang, Owen Tak-Yin
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2020
Fag:
Poster Abstracts
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7777368/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.755
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker